Simon Lee

In this study the authors identified breakthrough infections by performing extensive evaluations of health care workers who were symptomatic (including mild symptoms) or had known infection exposure.

This study randomly assigned participants who were enrolled within 96 hours after a household contact received a diagnosis of SARS-CoV-2 infection to receive a total dose of 1200mg of REGEN-COV or matching placebo administered by means of subcutaneous injection.

In this article the authors hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with COVID-19.

In this open-label, adaptive, multiplatform, randomized clinical trial, critically ill COVID-19 patients were randomly assigned to a regimen of either therapeutic-dose anticoagulation with heparin or pharmacologic thromboprophylaxis in accordance with local usual care.

In this trial, the authors assigned COVID-19 patients to receive either one unit of convalescent plasma with a high titer of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a placebo.

EAN Scientific Committee Chair, Thomas Berger, gives early notice of the upcoming elections for Scientific Panel Management Groups and an update on recent scientific activities.

Prof. Elena Lebedeva, member of the EAN Task Force on Gender and Diversity Issues in Neurology, interviews Prof. David Dodick, Professor of Neurology, Director of the Headache and Concussion Programs at Mayo Clinic in Arizona.

The European Academy of Neurology Board and Education Committee are pleased to announce the addition of four new e-Learning Associate Editors to the e-Learning Editorial Board. Together with Editor-in-Chief, Prof. Barbara Tettenborn, and the eLearning sub-committee, they will shape the future of EAN e-Learning activities.

The EAN-Day in Greece took place on 2 June, 2021, organised under the auspices of the EAN, the Hellenic Neurological Society and Professor Nikolaos Grigoriadis, the Head of the Hellenic Neurological Society.

Alzheimer Europe supported a call made on 25 June by European health NGOs, asking the European Commission to restore operating grants in the EU4Health Programme in order to support core activities of European NGOs.

In this article the authors aimed to analyse the range and prevalence of neurological and psychiatric complications associated with paediatric SARS-CoV-2 infection in hospitalised children and adolescents.

This paper aims to evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation from March 2020 to December 2020, and to investigate the association of SARS-CoV2 and Bell's palsy.

Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology

In this article the authors reviewed the scientific literature on movement disorders associated with Covid-19 published in English, spanning from the initial descriptions of COVID-19.

The objective of this multicentre retrospective cohort study was to develop and validate models that predict mortality of patients diagnosed with COVID-19 admitted to the hospital.